| # | Title | Journal | Year | Citations |
|---|
| 1 | The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis | Clinical and Experimental Rheumatology | 2005 | 417 |
| 2 | The Health Assessment Questionnaire (HAQ) | Clinical and Experimental Rheumatology | 2005 | 359 |
| 3 | The Disease Activity Score and the EULAR response criteria | Clinical and Experimental Rheumatology | 2005 | 342 |
| 4 | The IL-1 family and inflammatory diseases | Clinical and Experimental Rheumatology | 2002 | 338 |
| 5 | COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? | Clinical and Experimental Rheumatology | 2020 | 337 |
| 6 | The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses | Clinical and Experimental Rheumatology | 2005 | 313 |
| 7 | The promise of PROMIS: using item response theory to improve assessment of patient-reported outcomes | Clinical and Experimental Rheumatology | 2005 | 251 |
| 8 | COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? | Clinical and Experimental Rheumatology | 2020 | 249 |
| 9 | Mortality in rheumatoid arthritis: 2008 update | Clinical and Experimental Rheumatology | 2008 | 244 |
| 10 | Raynaud's phenomenon: a proposal for classification | Clinical and Experimental Rheumatology | 1992 | 215 |
| 11 | Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: a retrospective cohort study | Clinical and Experimental Rheumatology | 2008 | 212 |
| 12 | Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE | Clinical and Experimental Rheumatology | 1992 | 208 |
| 13 | Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19 | Clinical and Experimental Rheumatology | 2020 | 196 |
| 14 | Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis | Clinical and Experimental Rheumatology | 2006 | 194 |
| 15 | Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study | Clinical and Experimental Rheumatology | 2005 | 190 |
| 16 | Cytokine production, serum levels and disease activity in systemic lupus erythematosus | Clinical and Experimental Rheumatology | 2000 | 189 |
| 17 | The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis | Clinical and Experimental Rheumatology | 2016 | 179 |
| 18 | A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA) | Clinical and Experimental Rheumatology | 2001 | 178 |
| 19 | A study of sixty pregnancies in patients with the antiphospholipid syndrome | Clinical and Experimental Rheumatology | 1996 | 172 |
| 20 | The role of ultrasonography and magnetic resonance imaging in early rheumatoid arthritis | Clinical and Experimental Rheumatology | 2003 | 171 |
| 21 | Association between hepatitis C virus and mixed cryoglobulinemia [see comment] | Clinical and Experimental Rheumatology | 1991 | 163 |
| 22 | The central role of T cells in rheumatoid arthritis | Clinical and Experimental Rheumatology | 2007 | 163 |
| 23 | One year in review 2020: pathogenesis of rheumatoid arthritis | Clinical and Experimental Rheumatology | 0 | 162 |
| 24 | Synovitis-acne-pustulosis hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies? | Clinical and Experimental Rheumatology | 1988 | 161 |
| 25 | Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria | Clinical and Experimental Rheumatology | 1999 | 160 |
| 26 | The Fibromyalgia Impact Questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia | Clinical and Experimental Rheumatology | 2004 | 158 |
| 27 | Cerebral infarction in systemic lupus: association with anticardiolipin antibodies | Clinical and Experimental Rheumatology | 1984 | 157 |
| 28 | Behçet's disease: an update on the pathogenesis | Clinical and Experimental Rheumatology | 2001 | 150 |
| 29 | Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus | Clinical and Experimental Rheumatology | 1998 | 143 |
| 30 | Enigmas in familial Mediterranean fever (FMF) | Clinical and Experimental Rheumatology | 2001 | 143 |
| 31 | Estrogens, the immune response and autoimmunity | Clinical and Experimental Rheumatology | 1995 | 139 |
| 32 | Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trapping of a variety of oral bacterial DNAs | Clinical and Experimental Rheumatology | 2006 | 139 |
| 33 | Evaluation of an existing screening tool for psoriatic arthritis in people with psoriasis and the development of a new instrument: the Psoriasis Epidemiology Screening Tool (PEST) questionnaire | Clinical and Experimental Rheumatology | 2009 | 138 |
| 34 | Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies | Clinical and Experimental Rheumatology | 1996 | 134 |
| 35 | Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain | Clinical and Experimental Rheumatology | 2008 | 127 |
| 36 | Cytokine patterns in fibromyalgia and their correlation with clinical manifestations | Clinical and Experimental Rheumatology | 2007 | 121 |
| 37 | Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases | Clinical and Experimental Rheumatology | 1993 | 120 |
| 38 | Assessment of disease severity and prognosis | Clinical and Experimental Rheumatology | 2003 | 120 |
| 39 | Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe | Clinical and Experimental Rheumatology | 2006 | 120 |
| 40 | Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention | Clinical and Experimental Rheumatology | 2003 | 117 |
| 41 | Colour Doppler ultrasonography to detect pannus in knee joint synovitis | Clinical and Experimental Rheumatology | 2000 | 115 |
| 42 | Effect of long-term treatment with rituximab on pulmonary function and skin fibrosis in patients with diffuse systemic sclerosis | Clinical and Experimental Rheumatology | 2012 | 115 |
| 43 | Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis | Clinical and Experimental Rheumatology | 2001 | 113 |
| 44 | The anticardiolipin syndrome | Clinical and Experimental Rheumatology | 1985 | 112 |
| 45 | Sonographic analysis of enthesopathy in the lower extremities of patients with spondylarthropathy | Clinical and Experimental Rheumatology | 1994 | 111 |
| 46 | The WOMAC Knee and Hip Osteoarthritis Indices: development, validation, globalization and influence on the development of the AUSCAN Hand Osteoarthritis Indices | Clinical and Experimental Rheumatology | 2005 | 111 |
| 47 | CD4+CD25+ regulatory T cells in patients with Behçet's disease | Clinical and Experimental Rheumatology | 2006 | 110 |
| 48 | Diagnosing early rheumatoid arthritis (RA). What are the problems and opportunities? | Clinical and Experimental Rheumatology | 2003 | 109 |
| 49 | Intraarticular administration of platelet-rich plasma with biodegradable gelatin hydrogel microspheres prevents osteoarthritis progression in the rabbit knee | Clinical and Experimental Rheumatology | 2009 | 109 |
| 50 | Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients | Clinical and Experimental Rheumatology | 1999 | 108 |
